Partners with MediScan Systems to Increase Availability of Maternal and Neonatal Diagnostics CHENNAI, India–PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced that it has expanded its fetal, maternal and neonatal health screening capability in India, with the inauguration of the PerkinElmer Health […]
Continued Roll-out of Innovative Molecular Laboratory Developed Tests from Sequenom Center for Molecular Medicine SAN DIEGO — Sequenom, Inc. (Nasdaq:SQNM – News) today announced the launch of the SensiGeneâ„¢ Fetal(XY) (Fetal Sex Determination) test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company’s second laboratory developed […]
Runcorn, Cheshire, United Kingdom — Thermo Fisher Scientific Inc., announced that The Robert Jones and Agnes Hunt Orthopaedic and District Hospital (RJAH), the UK’s leading orthopedic hospital, has chosen the Thermo Scientific Excelsior ES tissue processor (NYSE: TMO). Thermo Fisher Scientific Inc., the world leader in serving science, today announced that The Robert Jones and […]
VENLO, The Netherlands, and ALAMEDA, California — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Celera Corporation (NASDAQ:CRA) today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II assay for detection of respiratory pathogens. Multiplex assays allow testing for […]
Cancer Diagnostics and Chromatography Products RUNCORN, Cheshire — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new cutting-edge facility in Runcorn, Cheshire. The new facility, located at Tudor Road, Manor Park, is a significant investment for Thermo Fisher Scientific in the North of England and is […]
The most ambitious European project for tackling bottlenecks in Alzheimer’s disease research and drug discovery PARIS — “The participation of ExonHit in this European initiative further validates our SpliceArray™ technology and our R&D expertise in Alzheimer’s disease” ExonHit Therapeutics S.A. (Paris:ALEHT) (Alternext: ALEHT) is pleased to announce that it has been chosen to participate in […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD). The license […]
HUNTINGTON BEACH, California and AMSTERDAM — Agendia, a world leader in molecular cancer diagnostics, announced today that it has received the Clinical Laboratory Permit from the New York State Department of Health. The New York State permit allows the company to receive commercial samples of MammaPrint, its FDA-cleared breast cancer recurrence test. With this latest […]
Patent Licensed From Johns Hopkins University for PCR-based Companion Diagnostics for Cancer Treatments VENLO, The Netherlands — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays. Research has […]
OMAHA, Neb. — Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced today that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies. These were detected in plasma samples in which the mutation […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
